{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:01:39Z","timestamp":1786114899059,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003052","name":"Korea Ministry of Trade Industry and Energy","doi-asserted-by":"publisher","award":["20018182"],"award-info":[{"award-number":["20018182"]}],"id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["2022R1C1C1012535"],"award-info":[{"award-number":["2022R1C1C1012535"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2024-00358576"],"award-info":[{"award-number":["RS-2024-00358576"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012421","name":"Agricultural Science and Technology Innovation Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012421","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Korea Ministry of Education","doi-asserted-by":"publisher","award":["RS-2023-00247986"],"award-info":[{"award-number":["RS-2023-00247986"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.tjpad.2025.100059","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T07:31:05Z","timestamp":1736494265000},"page":"100059","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Association between L-\u03b1 glycerylphosphorylcholine use and delayed dementia conversion: A nationwide longitudinal study in South Korea"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7650-6708","authenticated-orcid":false,"given":"Han-Kyeol","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6019-6912","authenticated-orcid":false,"given":"Sojeong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Seok","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Yong","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5404-7646","authenticated-orcid":false,"given":"Ickpyo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Seok","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tjpad.2025.100059_bib0001","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.tjpad.2025.100059_bib0002","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ana.21706","article-title":"The neuropathology of probable Alzheimer disease and mild cognitive impairment","volume":"66","author":"Schneider","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.tjpad.2025.100059_bib0003","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/15622975.2019.1696473","article-title":"Management of mild cognitive impairment (MCI): the need for national and international guidelines","volume":"21","author":"Kasper","year":"2020","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.tjpad.2025.100059_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.681492","article-title":"Determinants of growth in prescription drug spending using 2010\u20132019 health insurance claims data","volume":"12","author":"Lee","year":"2021","journal-title":"Front Pharmacol"},{"issue":"12","key":"10.1016\/j.tjpad.2025.100059_bib0005","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.neurobiolaging.2005.10.004","article-title":"Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia","volume":"27","author":"Rom\u00e1n","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.tjpad.2025.100059_bib0006","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","article-title":"The cholinergic hypothesis of Alzheimer's disease: a review of progress","volume":"66","author":"Francis","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.tjpad.2025.100059_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(98)00093-4","article-title":"Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease?","volume":"346","author":"Benzi","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.tjpad.2025.100059_bib0008","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0091-3057(91)90040-9","article-title":"Effect of a new cognition enhancer, alpha-glycerylphosphorylcholine, on scopolamine-induced amnesia and brain acetylcholine","volume":"39","author":"Lopez","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.tjpad.2025.100059_bib0009","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0014-2999(92)90392-H","article-title":"L-\u03b1-glycerylphorylcholine antagonizes scopolamine-induced amnesia and enhances hippocampal cholinergic transmission in the rat","volume":"211","author":"Sigala","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.tjpad.2025.100059_bib0010","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/S0047-6374(01)00310-4","article-title":"Treatment of cognitive dysfunction associated with Alzheimer's disease with cholinergic precursors. Ineffective treatments or inappropriate approaches?","volume":"122","author":"Amenta","year":"2001","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.tjpad.2025.100059_bib0011","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0149-2918(03)90023-3","article-title":"Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial","volume":"25","author":"De","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.tjpad.2025.100059_bib0012","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3233\/JAD-221189","article-title":"Activity of choline alphoscerate on adult-onset cognitive dysfunctions: a systematic review and meta-analysis","volume":"92","author":"Sagaro","year":"2023","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2025.100059_bib0013","doi-asserted-by":"crossref","first-page":"S281","DOI":"10.3233\/JAD-140150","article-title":"The ascomalva (Association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease) trial: interim results after two years of treatment","volume":"42","author":"Amenta","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2025.100059_bib0014","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.410100203","article-title":"Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis","volume":"10","author":"Whitehouse","year":"1981","journal-title":"Ann Neurol"},{"key":"10.1016\/j.tjpad.2025.100059_bib0015","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0022-510X(77)90073-9","article-title":"Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue","volume":"34","author":"Perry","year":"1977","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.tjpad.2025.100059_bib0016","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.conb.2006.09.002","article-title":"The role of acetylcholine in learning and memory","volume":"16","author":"Hasselmo","year":"2006","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.tjpad.2025.100059_bib0017","doi-asserted-by":"crossref","first-page":"624.e23","DOI":"10.1016\/j.neurobiolaging.2011.03.006","article-title":"Altered expression of brain acetylcholinesterase in FTDP-17 human tau transgenic mice","volume":"33","author":"Silveyra","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.tjpad.2025.100059_bib0018","doi-asserted-by":"crossref","first-page":"19377","DOI":"10.1074\/jbc.M111.321448","article-title":"Inhibition of choline acetyltransferase as a mechanism for cholinergic dysfunction induced by amyloid-beta peptide oligomers","volume":"287","author":"Nunes-Tavares","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tjpad.2025.100059_bib0019","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.2174\/092986706777935203","article-title":"Towards a unifying hypothesis of Alzheimer's disease: cholinergic system linked to plaques, tangles and neuroinflammation","volume":"13","author":"Sivaprakasam","year":"2006","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.tjpad.2025.100059_bib0020","doi-asserted-by":"crossref","first-page":"e13037","DOI":"10.1111\/acel.13037","article-title":"Lifelong choline supplementation ameliorates Alzheimer's disease pathology and associated cognitive deficits by attenuating microglia activation","volume":"18","author":"Velazquez","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.tjpad.2025.100059_bib0021","first-page":"34","article-title":"Dietary choline deficiency causes DNA strand breaks and alters epigenetic marks on DNA and histones","volume":"733","author":"Zeisel","year":"2012","journal-title":"Mutat Res"},{"key":"10.1016\/j.tjpad.2025.100059_bib0022","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/ajcn\/nqz244","article-title":"Choline and phosphatidylcholine may maintain cognitive performance by multiple mechanisms","volume":"110","author":"Shea","year":"2019","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.tjpad.2025.100059_bib0023","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jns.2012.07.003","article-title":"The ascomalva trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results","volume":"322","author":"Amenta","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.tjpad.2025.100059_bib0024","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3233\/JAD-141983","article-title":"Apathy treatment in Alzheimer's disease: interim results of the ascomalva trial","volume":"48","author":"Rea","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2025.100059_bib0025","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3233\/JAD-160675","article-title":"The effect of the association between donepezil and choline alphoscerate on behavioral disturbances in Alzheimer's disease: interim results of the ascomalva trial","volume":"56","author":"Carotenuto","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2025.100059_bib0026","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3233\/JAD-190623","article-title":"Volume analysis of brain cognitive areas in Alzheimer's disease: interim 3-year results from the ascomalva trial","volume":"76","author":"Traini","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2025.100059_bib0027","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3233\/ADR-200269","article-title":"Association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in the treatment of depression in patients with Alzheimer's disease","volume":"6","author":"Carotenuto","year":"2022","journal-title":"J Alzheimers Dis Rep"},{"key":"10.1016\/j.tjpad.2025.100059_bib0028","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.36008","article-title":"Association of l-alpha glycerylphosphorylcholine with subsequent stroke risk after 10 years","volume":"4","author":"Lee","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.tjpad.2025.100059_bib0029","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20190515","article-title":"Serum levels of trimethylamine-N-oxide in patients with ischemic stroke","volume":"39","author":"Rexidamu","year":"2019","journal-title":"Biosci Rep"},{"key":"10.1016\/j.tjpad.2025.100059_bib0030","doi-asserted-by":"crossref","first-page":"e1283","DOI":"10.1212\/WNL.0000000000005298","article-title":"Elevated trimethylamine N-oxide related to ischemic brain lesions after carotid artery stenting","volume":"90","author":"Wu","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2025.100059_bib0031","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1161\/STROKEAHA.118.021997","article-title":"Serum trimethylamine N-oxide concentration is positively associated with first stroke in hypertensive patients","volume":"49","author":"Nie","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.tjpad.2025.100059_bib0032","doi-asserted-by":"crossref","first-page":"13477","DOI":"10.3390\/ijms222413477","article-title":"The nutritional supplement l-alpha glycerylphosphorylcholine promotes atherosclerosis","volume":"22","author":"Wang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.tjpad.2025.100059_bib0033","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5853\/jos.2019.00472","article-title":"Gut microbiota and ischemic stroke: the role of trimethylamine N-oxide","volume":"21","author":"Nam","year":"2019","journal-title":"J Stroke"},{"key":"10.1016\/j.tjpad.2025.100059_bib0034","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.atherosclerosis.2016.01.033","article-title":"The carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis","volume":"247","author":"Skagen","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.tjpad.2025.100059_bib0035","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk","volume":"368","author":"Tang","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tjpad.2025.100059_bib0036","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.tjpad.2025.100059_bib0037","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/joim.13572","article-title":"Associations of plasma TMAO and its precursors with stroke risk in the general population: a nested case-control study","volume":"293","author":"Liu","year":"2023","journal-title":"J Intern Med"},{"key":"10.1016\/j.tjpad.2025.100059_bib0038","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/ajcn\/nqab199","article-title":"Plasma choline and betaine and risks of cardiovascular events and recurrent stroke after ischemic stroke","volume":"114","author":"Zhong","year":"2021","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.tjpad.2025.100059_bib0039","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/STROKEAHA.120.031903","article-title":"Choline pathway nutrients and metabolites and cognitive impairment after acute ischemic stroke","volume":"52","author":"Zhong","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.tjpad.2025.100059_bib0040","doi-asserted-by":"crossref","first-page":"119.e15","DOI":"10.1016\/j.neurobiolaging.2020.10.022","article-title":"Causal relationships between gut metabolites and Alzheimer's disease: a bidirectional Mendelian randomization study","volume":"100","author":"Zhuang","year":"2021","journal-title":"Neurobiol Aging"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725000032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725000032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T22:54:47Z","timestamp":1785970487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580725000032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2274580725000032"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100059","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between L-\u03b1 glycerylphosphorylcholine use and delayed dementia conversion: A nationwide longitudinal study in South Korea","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100059"}}